ATP7A Antibodies

Santa Cruz Biotechnology provides a broad selection of ATP7A monoclonal antibodies for research focused on understanding ATP7A protein function. ATP7A monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATP7A, also known as Menkes protein, plays a vital role in copper transport and homeostasis in the body. Deficiencies or mutations in the ATP7A gene can lead to Menkes disease, a severe neurodegenerative disorder characterized by copper deficiency. Understanding ATP7A function is essential for identifying its role in cellular processes and potential therapeutic targets for related diseases. ATP7A monoclonal antibodies enable researchers to investigate copper metabolism mechanisms and their impact on health and disease. ATP7A research continues to reveal new insights into copper transport pathways and their connection to neurological disorders. ATP7A monoclonal antibodies support cutting-edge research that advances scientific understanding of copper-related disorders and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies for ATP7A contribute to advancing scientific knowledge and therapeutic development in the research community.